APO Research
Talk to an analyst

APO RESEARCH · REPORT

Influenza Treatment

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Influenza Treatment Industry Growth and Trends Forecast to 2032

20 December 2025100 pages

Choose your research edition.

Industry ResearchInfluenza Treatment Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Influenza Treatment Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Influenza Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Influenza Treatment Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Influenza Treatment Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

According to APO Research, the global Influenza Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Influenza Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Influenza Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Influenza Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Influenza Treatment market include Sanofi, Novartis AG, GSK plc., Daiichi Sankyo, AstraZeneca, Viatris Inc. (Mylan), Teva Pharmaceutical Industries Ltd., Roche Holding and NATCO Pharma Limited, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Influenza Treatment market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Influenza Treatment market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Influenza Treatment market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Influenza Treatment.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Influenza Treatment market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Influenza Treatment Market by Company

Sanofi

Novartis AG

GSK plc.

Daiichi Sankyo

AstraZeneca

Viatris Inc. (Mylan)

Teva Pharmaceutical Industries Ltd.

Roche Holding

NATCO Pharma Limited

Gilead Sciences

BioCryst Pharmaceuticals

Influenza Treatment Segment by Type

Zanamivir

Peramivir

Oseltamivir Phosphate

Baloxavir Marboxil

Others

Influenza Treatment Segment by Application

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Influenza Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Influenza Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Influenza Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Influenza Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Influenza Treatment companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Influenza Treatment Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Influenza Treatment Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Influenza Treatment Market Share by Region (2021-2026) Table 4. Global Influenza Treatment Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Influenza Treatment Market Share by Region (2027-2032) Table 6. Global Influenza Treatment Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Influenza Treatment Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Influenza Treatment Market Size Share by Type (2021-2026) Table 9. Global Influenza Treatment Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Influenza Treatment Market Size Share Forecasted by Type (2027-2032) Table 11. North America Influenza Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Influenza Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Influenza Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Influenza Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Influenza Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Influenza Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Influenza Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Influenza Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Influenza Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Influenza Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Influenza Treatment Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Influenza Treatment Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Influenza Treatment Market Size Share by Application (2021-2026) Table 24. Global Influenza Treatment Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Influenza Treatment Market Size Share Forecasted by Application (2027-2032) Table 26. North America Influenza Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Influenza Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Influenza Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Influenza Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Influenza Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Influenza Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Influenza Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Influenza Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Influenza Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Influenza Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Influenza Treatment Industry Trends Table 37. Influenza Treatment Industry Drivers Table 38. Influenza Treatment Industry Opportunities and Challenges Table 39. Influenza Treatment Industry Restraints Table 40. Global Influenza Treatment Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Influenza Treatment Revenue Market Share by Company (2021-2026) Table 42. Global Influenza Treatment Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Influenza Treatment Key Company Headquarters & Area Served Table 44. Global Influenza Treatment Company, Product Type & Application Table 45. Global Influenza Treatment Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Influenza Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Sanofi Company Information Table 49. Sanofi Business Overview Table 50. Sanofi Influenza Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Sanofi Influenza Treatment Product Portfolio Table 52. Sanofi Recent Development Table 53. Novartis AG Company Information Table 54. Novartis AG Business Overview Table 55. Novartis AG Influenza Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Novartis AG Influenza Treatment Product Portfolio Table 57. Novartis AG Recent Development Table 58. GSK plc. Company Information Table 59. GSK plc. Business Overview Table 60. GSK plc. Influenza Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. GSK plc. Influenza Treatment Product Portfolio Table 62. GSK plc. Recent Development Table 63. Daiichi Sankyo Company Information Table 64. Daiichi Sankyo Business Overview Table 65. Daiichi Sankyo Influenza Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Daiichi Sankyo Influenza Treatment Product Portfolio Table 67. Daiichi Sankyo Recent Development Table 68. AstraZeneca Company Information Table 69. AstraZeneca Business Overview Table 70. AstraZeneca Influenza Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. AstraZeneca Influenza Treatment Product Portfolio Table 72. AstraZeneca Recent Development Table 73. Viatris Inc. (Mylan) Company Information Table 74. Viatris Inc. (Mylan) Business Overview Table 75. Viatris Inc. (Mylan) Influenza Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Viatris Inc. (Mylan) Influenza Treatment Product Portfolio Table 77. Viatris Inc. (Mylan) Recent Development Table 78. Teva Pharmaceutical Industries Ltd. Company Information Table 79. Teva Pharmaceutical Industries Ltd. Business Overview Table 80. Teva Pharmaceutical Industries Ltd. Influenza Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Teva Pharmaceutical Industries Ltd. Influenza Treatment Product Portfolio Table 82. Teva Pharmaceutical Industries Ltd. Recent Development Table 83. Roche Holding Company Information Table 84. Roche Holding Business Overview Table 85. Roche Holding Influenza Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Roche Holding Influenza Treatment Product Portfolio Table 87. Roche Holding Recent Development Table 88. NATCO Pharma Limited Company Information Table 89. NATCO Pharma Limited Business Overview Table 90. NATCO Pharma Limited Influenza Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. NATCO Pharma Limited Influenza Treatment Product Portfolio Table 92. NATCO Pharma Limited Recent Development Table 93. Gilead Sciences Company Information Table 94. Gilead Sciences Business Overview Table 95. Gilead Sciences Influenza Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Gilead Sciences Influenza Treatment Product Portfolio Table 97. Gilead Sciences Recent Development Table 98. BioCryst Pharmaceuticals Company Information Table 99. BioCryst Pharmaceuticals Business Overview Table 100. BioCryst Pharmaceuticals Influenza Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. BioCryst Pharmaceuticals Influenza Treatment Product Portfolio Table 102. BioCryst Pharmaceuticals Recent Development Table 103. North America Influenza Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. North America Influenza Treatment Market Size by Country (2021-2026) & (US$ Million) Table 105. North America Influenza Treatment Market Share by Country (2021-2026) Table 106. North America Influenza Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. North America Influenza Treatment Market Share Forecast by Country (2027-2032) Table 108. Europe Influenza Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. Europe Influenza Treatment Market Size by Country (2021-2026) & (US$ Million) Table 110. Europe Influenza Treatment Market Share by Country (2021-2026) Table 111. Europe Influenza Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. Europe Influenza Treatment Market Share Forecast by Country (2027-2032) Table 113. Asia-Pacific Influenza Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Asia-Pacific Influenza Treatment Market Size by Country (2021-2026) & (US$ Million) Table 115. Asia-Pacific Influenza Treatment Market Share by Country (2021-2026) Table 116. Asia-Pacific Influenza Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Asia-Pacific Influenza Treatment Market Share Forecast by Country (2027-2032) Table 118. Latin America Influenza Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Latin America Influenza Treatment Market Size by Country (2021-2026) & (US$ Million) Table 120. Latin America Influenza Treatment Market Share by Country (2021-2026) Table 121. Latin America Influenza Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Latin America Influenza Treatment Market Share Forecast by Country (2027-2032) Table 123. Middle East & Africa Influenza Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Middle East & Africa Influenza Treatment Market Size by Country (2021-2026) & (US$ Million) Table 125. Middle East & Africa Influenza Treatment Market Share by Country (2021-2026) Table 126. Middle East & Africa Influenza Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Middle East & Africa Influenza Treatment Market Share Forecast by Country (2027-2032) Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Influenza Treatment Product Image Figure 3. Global Influenza Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Influenza Treatment Market Size (2021-2032) & (US$ Million) Figure 5. Global Influenza Treatment Market Share by Region: 2025 VS 2032 Figure 6. Global Influenza Treatment Market Share by Region (2021-2032) Figure 7. North America Influenza Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Influenza Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Influenza Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Influenza Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Influenza Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Zanamivir Image Figure 13. Global Zanamivir Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Peramivir Image Figure 15. Global Peramivir Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Oseltamivir Phosphate Image Figure 17. Global Oseltamivir Phosphate Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Baloxavir Marboxil Image Figure 19. Global Baloxavir Marboxil Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Others Image Figure 21. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. Global Influenza Treatment Market Size Overview by Type (2021-2032) & (US$ Million) Figure 23. Global Influenza Treatment Market Share by Type 2025 VS 2032 Figure 24. North America Influenza Treatment Market Size Share by Type (2021-2032) Figure 25. Europe Influenza Treatment Market Size Share by Type (2021-2032) Figure 26. Asia-Pacific Influenza Treatment Market Size Share by Type (2021-2032) Figure 27. Latin America Influenza Treatment Market Size Share by Type (2021-2032) Figure 28. Middle East and Africa Influenza Treatment Market Size Share by Type (2021-2032) Figure 29. Hospital Pharmacies Image Figure 30. Global Hospital Pharmacies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Online Pharmacies Image Figure 32. Global Online Pharmacies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Retail Pharmacies Image Figure 34. Global Retail Pharmacies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Global Influenza Treatment Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Influenza Treatment Market Share by Application 2025 VS 2032 Figure 37. North America Influenza Treatment Market Size Share by Application (2021-2032) Figure 38. Europe Influenza Treatment Market Size Share by Application (2021-2032) Figure 39. Asia-Pacific Influenza Treatment Market Size Share by Application (2021-2032) Figure 40. Latin America Influenza Treatment Market Size Share by Application (2021-2032) Figure 41. Middle East and Africa Influenza Treatment Market Size Share by Application (2021-2032) Figure 42. Global Top 5 and 10 Influenza Treatment Players Market Share by Revenue in 2025 Figure 43. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 44. North America Influenza Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. North America Influenza Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. North America Influenza Treatment Market Share by Country (2021-2032) Figure 47. Europe Influenza Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Influenza Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Influenza Treatment Market Share by Country (2021-2032) Figure 50. Asia-Pacific Influenza Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Asia-Pacific Influenza Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Asia-Pacific Influenza Treatment Market Share by Country (2021-2032) Figure 53. Latin America Influenza Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Influenza Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Influenza Treatment Market Share by Country (2021-2032) Figure 56. Middle East & Africa Influenza Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Middle East & Africa Influenza Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 58. Middle East & Africa Influenza Treatment Market Share by Country (2021-2032) Figure 59. Years Considered Figure 60. Research Process Figure 61. Key Executives Interviewed

Scope & coverage.

Types
  • Zanamivir
  • Peramivir
  • Oseltamivir Phosphate
  • Baloxavir Marboxil
  • Others
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • Sanofi
  • Novartis AG
  • GSK plc.
  • Daiichi Sankyo
  • AstraZeneca
  • Viatris Inc. (Mylan)
  • Teva Pharmaceutical Industries Ltd.
  • Roche Holding
  • NATCO Pharma Limited
  • Gilead Sciences
  • BioCryst Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Influenza Treatment Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Influenza Treatment Market Size by Region (2021-2032)
  5. 1.4.1 Global Influenza Treatment Market Size by Region (2021-2026)
  6. 1.4.2 Global Influenza Treatment Market Size by Region (2027-2032)
  7. 1.5 Key Regions Influenza Treatment Market Size (2021-2032)
  8. 1.5.1 North America Influenza Treatment Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Influenza Treatment Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Influenza Treatment Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Influenza Treatment Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Influenza Treatment Market Size Growth Rate (2021-2032)
2 Influenza Treatment Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Zanamivir
  3. 2.1.2 Peramivir
  4. 2.1.3 Oseltamivir Phosphate
  5. 2.1.4 Baloxavir Marboxil
  6. 2.1.5 Others
  7. 2.2 Global Influenza Treatment Market Size by Type
  8. 2.2.1 Global Influenza Treatment Market Size Overview by Type (2021-2032)
  9. 2.2.2 Global Influenza Treatment Historic Market Size Review by Type (2021-2026)
  10. 2.2.3 Global Influenza Treatment Market Size Forecasted by Type (2027-2032)
  11. 2.3 Global Influenza Treatment Market Size by Regions
  12. 2.3.1 North America Influenza Treatment Market Size Breakdown by Type (2021-2026)
  13. 2.3.2 Europe Influenza Treatment Market Size Breakdown by Type (2021-2026)
  14. 2.3.3 Asia-Pacific Influenza Treatment Market Size Breakdown by Type (2021-2026)
  15. 2.3.4 South America Influenza Treatment Market Size Breakdown by Type (2021-2026)
  16. 2.3.5 Middle East and Africa Influenza Treatment Market Size Breakdown by Type (2021-2026)
3 Influenza Treatment Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospital Pharmacies
  3. 3.1.2 Online Pharmacies
  4. 3.1.3 Retail Pharmacies
  5. 3.2 Global Influenza Treatment Market Size by Application
  6. 3.2.1 Global Influenza Treatment Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Influenza Treatment Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Influenza Treatment Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Influenza Treatment Market Size by Regions
  10. 3.3.1 North America Influenza Treatment Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Influenza Treatment Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Influenza Treatment Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Influenza Treatment Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Influenza Treatment Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Influenza Treatment Industry Trends
  2. 4.2 Influenza Treatment Industry Drivers
  3. 4.3 Influenza Treatment Industry Opportunities and Challenges
  4. 4.4 Influenza Treatment Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Influenza Treatment Revenue (2021-2026)
  2. 5.2 Global Influenza Treatment Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Influenza Treatment Key Company Headquarters & Area Served
  4. 5.4 Global Influenza Treatment Company, Product Type & Application
  5. 5.5 Global Influenza Treatment Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Influenza Treatment Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Influenza Treatment Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Influenza Treatment Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Sanofi
  2. 6.1.1 Sanofi Company Information
  3. 6.1.2 Sanofi Business Overview
  4. 6.1.3 Sanofi Influenza Treatment Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi Influenza Treatment Product Portfolio
  6. 6.1.5 Sanofi Recent Developments
  7. 6.2 Novartis AG
  8. 6.2.1 Novartis AG Company Information
  9. 6.2.2 Novartis AG Business Overview
  10. 6.2.3 Novartis AG Influenza Treatment Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Novartis AG Influenza Treatment Product Portfolio
  12. 6.2.5 Novartis AG Recent Developments
  13. 6.3 GSK plc.
  14. 6.3.1 GSK plc. Company Information
  15. 6.3.2 GSK plc. Business Overview
  16. 6.3.3 GSK plc. Influenza Treatment Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 GSK plc. Influenza Treatment Product Portfolio
  18. 6.3.5 GSK plc. Recent Developments
  19. 6.4 Daiichi Sankyo
  20. 6.4.1 Daiichi Sankyo Company Information
  21. 6.4.2 Daiichi Sankyo Business Overview
  22. 6.4.3 Daiichi Sankyo Influenza Treatment Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Daiichi Sankyo Influenza Treatment Product Portfolio
  24. 6.4.5 Daiichi Sankyo Recent Developments
  25. 6.5 AstraZeneca
  26. 6.5.1 AstraZeneca Company Information
  27. 6.5.2 AstraZeneca Business Overview
  28. 6.5.3 AstraZeneca Influenza Treatment Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 AstraZeneca Influenza Treatment Product Portfolio
  30. 6.5.5 AstraZeneca Recent Developments
  31. 6.6 Viatris Inc. (Mylan)
  32. 6.6.1 Viatris Inc. (Mylan) Company Information
  33. 6.6.2 Viatris Inc. (Mylan) Business Overview
  34. 6.6.3 Viatris Inc. (Mylan) Influenza Treatment Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Viatris Inc. (Mylan) Influenza Treatment Product Portfolio
  36. 6.6.5 Viatris Inc. (Mylan) Recent Developments
  37. 6.7 Teva Pharmaceutical Industries Ltd.
  38. 6.7.1 Teva Pharmaceutical Industries Ltd. Company Information
  39. 6.7.2 Teva Pharmaceutical Industries Ltd. Business Overview
  40. 6.7.3 Teva Pharmaceutical Industries Ltd. Influenza Treatment Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Teva Pharmaceutical Industries Ltd. Influenza Treatment Product Portfolio
  42. 6.7.5 Teva Pharmaceutical Industries Ltd. Recent Developments
  43. 6.8 Roche Holding
  44. 6.8.1 Roche Holding Company Information
  45. 6.8.2 Roche Holding Business Overview
  46. 6.8.3 Roche Holding Influenza Treatment Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Roche Holding Influenza Treatment Product Portfolio
  48. 6.8.5 Roche Holding Recent Developments
  49. 6.9 NATCO Pharma Limited
  50. 6.9.1 NATCO Pharma Limited Company Information
  51. 6.9.2 NATCO Pharma Limited Business Overview
  52. 6.9.3 NATCO Pharma Limited Influenza Treatment Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 NATCO Pharma Limited Influenza Treatment Product Portfolio
  54. 6.9.5 NATCO Pharma Limited Recent Developments
  55. 6.10 Gilead Sciences
  56. 6.10.1 Gilead Sciences Company Information
  57. 6.10.2 Gilead Sciences Business Overview
  58. 6.10.3 Gilead Sciences Influenza Treatment Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Gilead Sciences Influenza Treatment Product Portfolio
  60. 6.10.5 Gilead Sciences Recent Developments
  61. 6.11 BioCryst Pharmaceuticals
  62. 6.11.1 BioCryst Pharmaceuticals Company Information
  63. 6.11.2 BioCryst Pharmaceuticals Business Overview
  64. 6.11.3 BioCryst Pharmaceuticals Influenza Treatment Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 BioCryst Pharmaceuticals Influenza Treatment Product Portfolio
  66. 6.11.5 BioCryst Pharmaceuticals Recent Developments
7 North America
  1. 7.1 North America Influenza Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Influenza Treatment Market Size by Country (2021-2026)
  3. 7.3 North America Influenza Treatment Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Influenza Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Influenza Treatment Market Size by Country (2021-2026)
  3. 8.3 Europe Influenza Treatment Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Influenza Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Influenza Treatment Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Influenza Treatment Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Influenza Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Influenza Treatment Market Size by Country (2021-2026)
  3. 10.3 South America Influenza Treatment Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Influenza Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Influenza Treatment Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Influenza Treatment Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst